Four years non-diabetic status after impaired glucose tolerance diagnosis cuts cardiovascular risks

FHS
July 11, 2024
2:42 am

Maintaining non-diabetic status for at least four years after impaired glucose tolerance diagnosis significantly lowers the risk of cardiovascular complications and mortality.

Novel vaccine lowers LDL cholesterol independent of statins

The effectiveness of virus-like particle (VLP)-based vaccines targeting epitopes in the low-density lipoprotein (LDL) receptor.

October 2, 2023

Evenamide substantially improves patients to an extent that they no longer meet protocol entry criteria – Biotech Investments

EQS-News: Newron Pharmaceuticals S.p.A. / Key word(s): Conference/Study results Newron TRS study 6 months’ results: Evenamide substantially improves patients to an extent that they no

October 10, 2023

Delaying Esophageal Cancer Surgery After Neoadjuvant CRT Fails in Trial

Prolonging the time to surgery following neoadjuvant chemoradiotherapy (CRT) for esophageal cancer failed to improve histological complete response rates and may even worsen overall survival

September 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.